
Our Global Reach
One Standard.
Every Market.
Regulatory requirements shift from one market to the next, but the quality of your compliance shouldn't. Vigilare Biopharma delivers consistent pharmacovigilance and regulatory support across every region where our clients operate.

A Unified Global Delivery Model
Rather than routing work through disconnected regional offices, Vigilare operates a unified global delivery model: one point of contact, one quality standard, and coordinated teams working across time zones.
Each region carries its own submission formats, reporting timelines, and health authority expectations. Our regulatory intelligence function continuously tracks these requirements so your programs stay compliant as regulations evolve.
- One point of contact across every market
- One consistent quality standard worldwide
- Coordinated teams across time zones
- Continuous multi-region regulatory tracking
North America, Europe, APAC & MEA
Consistent pharmacovigilance and regulatory support across six regions.
North America
FDA submissions, US pharmacovigilance, and adverse event reporting.
Europe
EMA and national competent authority submissions, EU MDR, GVP-aligned PV.
United Kingdom
MHRA post-Brexit regulatory strategy and safety reporting.
Canada
Health Canada submissions and PV compliance.
Australia
TGA regulatory support and device registrations.
Middle East & Africa
MOH liaison and registration support across key growth markets.
Multi-Region Compliance Expertise
One coordinated engagement instead of separate local vendors.
Regulatory Intelligence
Our intelligence function tracks each region's submission formats, timelines and expectations so your programs stay compliant as rules change.
One Coordinated Engagement
A single accountable partner across regions — not separate vendors for each market.
Across Time Zones
Coordinated teams keep submissions and safety reporting on schedule worldwide.
Answered. Clearly.
01
Do CROs provide services globally?
Yes — global CROs like Vigilare Biopharma support pharmacovigilance, regulatory submissions, and compliance activities across multiple countries and regions through a single coordinated engagement, rather than requiring separate local vendors for each market.
02
Which countries require pharmacovigilance compliance?
Most countries with an active pharmaceutical regulatory framework — including the US, EU member states, the UK, Canada, and Australia — require ongoing pharmacovigilance activities for any marketed drug product, though specific reporting requirements vary by jurisdiction.
Related Practice
Talk to our team about entering new regulatory markets.
Expand globally with one partner, one quality standard, and coordinated teams across every region.